Biologics Contract Manufacturing
Oct 22, 2026
ProBio Announces Completion of NMPA Pre-Approval Inspection at Its China Manufacturing Facility; Providence Medical Secures FDA Approval for CORUS PCSS 3D-T Spinal Device; Sony Semiconductor Solutions Launches Compact Image Sensor for Single-Use Endoscopes; Ping An Launches China’s First Comprehensive Alzheimer’s Disease Brain Health Management Program; Geneos Therapeutics Advances Personalized DNA Immunotherapy for Liver Cancer into Phase 2; Medtronic Reports Positive Real-World Data for Sphere-9 and PulseSelect PFA
ProBio Completed NMPA Pre-Approval Inspection at Its Biologics Manufacturing Facility in China On 21 October 2026, ProBio Inc. announced the successful completion of a pre-approval inspection conducted by China’s National Medical Products Administration (NMPA) at its biologics manufacturing facility in Nan...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
